DALLAS, March 15,
2023 /PRNewswire/ -- SWK Holdings Corporation
(Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused
specialty finance company catering to small- and mid-sized
commercial-stage companies, today announced that Jerry Albright has been named to the Company's
Board of Directors and will replace Wendy
DiCicco, who chose not to seek re-election to the Board
because of external professional commitments. The transition
will be effective March 15, 2023,
with Mr. Albright joining Board Chair, Laurie Dotter, and directors, Robert K. Hatcher, and Marcus Pennington, on the Board.
"We are pleased to welcome Jerry to SWK's Board of Directors and
look forward to benefitting from his extensive investment and
banking experience as we continue to target opportunities to
maximize SWK's position as a partner of choice for small- and
mid-sized healthcare companies seeking non-dilutive financing to
fuel growth," stated Ms. Dotter. "We believe Jerry's expertise in
board protocols and practices should allow for a seamless
transition from Ms. DiCicco, who has served on our Board since
February 2022. During her tenure,
Wendy provided valuable industry insights to the management team
and her colleagues on the Board and was instrumental in revamping
our executive compensation program, which now more closely aligns
our management team with shareholders. On behalf of the leadership
team and Board, we thank Wendy for her contributions."
Mr. Albright is currently a managing partner of ADIM, LLC, an
investment management firm specializing in establishing protocols,
policies, and practices for boards of directors. Prior to
ADIM, Mr. Albright held multiple roles of increasing responsibility
at the Teacher Retirement System of Texas ("TRS") for nearly three decades until
his retirement in May 2020, including
as TRS Investment Division's Deputy Chief Investment Officer, Chief
Operating Officer, Director of Investment Operations and, most
recently, as its Chief Investment Officer, in which capacity he
served from mid-2017 until his retirement. Prior to joining
TRS, Mr. Albright was the Executive Vice President and a member of
the board of directors of a multi-bank holding company in
Texas, in addition to serving as a
director on the board of two affiliated banks. Mr. Albright
has also previously served on the Advisory Board of the Finance
Department at Texas A&M University.
Mr. Albright holds a bachelor's degree in economics from
Texas A&M University.
"Jerry is an excellent addition to the Board and arrives at a
time of opportunity for SWK given the dynamics within the capital
markets that we believe continue to make our suite of financing
solutions enticing to life science companies in need of capital,"
stated Mr. Hatcher. "We wish Wendy the very best as she
continues to serve as an advisor to companies in the healthcare
sector, including SWK portfolio companies."
About SWK Holdings Corporation
SWK Holdings
Corporation is a life science focused specialty finance company
partnering with small- and mid-sized commercial-stage healthcare
companies. SWK provides non-dilutive financing to fuel the
development and commercialization of lifesaving and life-enhancing
medical technologies and products. SWK's unique financing
structures provide flexible financing solutions at an attractive
cost of capital to create long-term value for all SWK stakeholders.
SWK's solutions include structured debt, traditional royalty
monetization, synthetic royalty transactions, and asset purchases
typically ranging in size from $5.0
million to $25.0
million. SWK also owns Enteris BioPharma, whose
Peptelligence® and ProPerma® drug delivery technologies
create oral formulations of peptide-based and BCS class II, III,
and IV small molecules. Additional information on the life science
finance market is available on the Company's website at
www.swkhold.com.
Safe Harbor Statement
This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Statements including
words such as "believes," "expects," "anticipates," "intends,"
"estimates," "plan," "will," "may," "look forward," "intend,"
"guidance," "future" or similar expressions are forward-looking
statements. Because these statements reflect SWK's current views,
expectations and beliefs concerning future events, these
forward-looking statements involve risks and uncertainties.
Investors should note that many factors, as more fully described
under the caption "Risk Factors" and elsewhere in SWK's Form 10-K,
Form 10-Q and Form 8-K filings with the Securities and Exchange
Commission and as otherwise enumerated herein, could affect the
Company's future financial results and could cause actual results
to differ materially from those expressed in such forward-looking
statements. The forward-looking statements in this press release
are qualified by these risk factors. These are factors which,
individually or in the aggregate, could cause the Company's actual
results to differ materially from expected and historical results.
You should not place undue reliance on any forward-looking
statements, which speak only as of the date they are made. We
assume no obligation to publicly update any forward-looking
statements, whether as a result of new information, future
developments or otherwise.
View original
content:https://www.prnewswire.com/news-releases/swk-holdings-appoints-jerry-albright-to-board-of-directors-301773310.html
SOURCE SWK Holdings Corporation
